{"id":"NCT03960580","sponsor":"Optinose US Inc.","briefTitle":"Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps","officialTitle":"A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 μg of OPN-375 Twice a Day (BID) in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-06","primaryCompletion":"2022-05-04","completion":"2022-05-04","firstPosted":"2019-05-23","resultsPosted":"2023-12-21","lastUpdate":"2023-12-21"},"enrollment":223,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Rhinosinusitis"],"interventions":[{"type":"DRUG","name":"OPN-375","otherNames":[]}],"arms":[{"label":"OPN-375 186 μg BID","type":"ACTIVE_COMPARATOR"},{"label":"OPN-375 372 μg BID","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a 24-week randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of intranasal administration of 186 and 372 μg twice daily (BID) of OPN-375 in subjects with chronic Rhinosinusitis (CRS) without nasal polyps","primaryOutcome":{"measure":"Change From Baseline in Symptoms as Measured by a Composite Score for Each Symptom of Nasal Congestion, Facial Pain or Pressure Sensation, and Nasal Discharge (Anterior and/or Posterior) at the End of Week 4","timeFrame":"4 Weeks","effectByArm":[{"arm":"Placebo","deltaMin":-0.81,"sd":0.202},{"arm":"OPN-375 186 μg BID","deltaMin":-1.54,"sd":0.204},{"arm":"OPN-375 372 μg BID","deltaMin":-1.74,"sd":0.204}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":87,"countries":["United States","Australia","Bulgaria","Czechia","Georgia","New Zealand","Poland","Romania","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":75},"commonTop":["Headache","COVID-19","Nasopharyngitis","Epistaxis","Chronic Sinusitis"]}}